Equities research analysts at Leerink Partners assumed coverage on shares of Elanco Animal Health (NYSE:ELAN – Get Free ...
Amylin analogs present a strong alternative or complement to GLP-1 receptor agonists, potentially eliciting higher-quality ...
Investment analysts at Leerink Partners began coverage on shares of Climb Bio (NASDAQ:CLYM – Get Free Report) in a report released on Monday, MarketBeat reports. The brokerage set an “outperform” ...
Fintel reports that on December 2, 2024, Leerink Partners initiated coverage of Zoetis (NYSE:ZTS) with a Outperform ...
Fintel on MSN2d
Leerink Partners Initiates Coverage of Elanco Animal Health (ELAN) with Market Perform RecommendationFintel reports that on December 2, 2024, Leerink Partners initiated coverage of Elanco Animal Health (NYSE:ELAN) with a ...
In recent trading, Teladoc Health Inc (TDOC) stock price has shown some volatility, fluctuating -8.90% over the last five trades and 18.89% over the past 30 trades. This represents a notable shift ...
Our analysis of options history for AbbVie ABBV revealed 13 unusual trades. Delving into the details, we found 46% of traders ...
While early and from a small trial, the findings suggest Janux’s method of “masking” T cell engagers could lead to ...
Shares of Eli Lilly climbed early Wednesday after the drugmaker detailed a study showing that its blockbuster weight-loss ...
Zacks.com on MSN9d
AbbVie Stock Rises After Leerink Partners Upgrades Its RatingAbbVie shares rose after a Leerink Partners analyst upgraded the stock's rating to outperform. The improved rating comes ...
AbbVie (ABBV) shares jump after Leerink Partners upgraded the stock to Outperform, saying the recent sell-off creates an ...
2d
The FDA approval represented the first significant innovation in the approach used to treat schizophrenia in decades.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback